DERMHAGE Fine Touch (1 x 1ml)

DERMHAGE products provide safe and long-lasting results for patients while utilising groundbreaking and patented Smooth Rheology Hyaluronic Acid (SRHA) technology. SHRA technology preserves the natural qualities of pure HA and combined with a premium syringe improves safety and control for practitioners, guaranteeing a smooth, precise and homogeneous application.

There are four products in the range with varying molecular weights, allowing practitioners to offer a bespoke treatment plan for patients of all genders, ages, skin types and with a range of concerns:

• 20mg/ml HA concentration 
• For soft tissue correction and fine lines including crows’ feet, tear troughs, acne scarring, stretch marks, and smokers’ lines. 
• Depth of injection: between dermal and epidermal layers, superficial to supraperiostal. 
• Injection techniques: papula or micro-papula, threading, blanching. 
• Effect duration: 6 to 9 months 
• Clinical trials have proven DERMHAGE fillers best resemble Juvederm and Restylane
• DERMHAGE fillers are available at a more commercial price

Key Features:

• Patented SHRA technology 
• Lab tested and found to resemble Juvederm and Restylane 
• Class III Medical Device with CE Mark 0483 and ISO 13485 
• Designed and made in the EU using pure French HA 
• Low extrusion force 
• Premium syringe for better safety, control and comfort 
• Extra precision with visual graduation 
• 1 x 1ml per unit 
• Includes 2 x thin 27G x ½” Terumo needles 
• 36-month shelf life 
• Immediately visible results with excellent product projection

Dermhage Must Not Be Used In: 

• People under the age of 18
• Women who are pregnant or breastfeeding
• Patients who are known to have a sensitivity to hyaluronic acid
• Immediately before or post chemical peeling, laser therapy or dermabrasion
• Areas presenting signs of infection or cutaneous inflammation
• Patients who tend to develop hypertrophic scarring